Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of -0.74% is 89% above its 5-year average of -6.89%, near the high end of its 5-year range (-44.09%–3.77%).
62.30% above its 12-month average of -1.96%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): 3.77%.
OPERATING MARGIN
-0.74%
OPERATING MARGIN AVG TTM
-1.96%
OPERATING MARGIN AVG 3Y
-4.35%
OPERATING MARGIN AVG 5Y
-6.89%
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+62.30%
CURRENT VS 3Y AVG
+82.98%
CURRENT VS 5Y AVG
+89.26%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 373 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Clover Health Investments, Corp.
Market Cap
$2.43B
Operating Margin
-0.74%
TTM Avg
-1.96%
3Y Avg
-4.35%
5Y Avg
-6.89%
Market Cap
$2.34B
Operating Margin
42.26%
TTM Avg
35.06%
3Y Avg
13.24%
5Y Avg
-28.82%
Market Cap
$2.51B
Operating Margin
-867.87%
TTM Avg
-840.98%
3Y Avg
-774.76%
5Y Avg
-1234.34%
Market Cap
$2.64B
Operating Margin
-274.57%
TTM Avg
-464.41%
3Y Avg
-382.79%
5Y Avg
-92575.80%
Market Cap
$2.64B
Operating Margin
-42.22%
TTM Avg
-21.11%
3Y Avg
-21.11%
5Y Avg
-21.11%
Market Cap
$2.17B
Operating Margin
-19160.00%
TTM Avg
-10969.44%
3Y Avg
-7268.29%
5Y Avg
-5243.17%
Market Cap
$2.69B
Operating Margin
10.06%
TTM Avg
14.13%
3Y Avg
15.87%
5Y Avg
13.57%
Market Cap
$2.69B
Operating Margin
11.12%
TTM Avg
10.91%
3Y Avg
6.08%
5Y Avg
-3.97%
Market Cap
$2.11B
Operating Margin
10.04%
TTM Avg
9.32%
3Y Avg
8.61%
5Y Avg
7.98%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Clover Health Investments, Corp. (CLOV) | $2.43B | -0.74% | -1.96% | -4.35% | -6.89% |
| ADMA Biologics, Inc. (ADMA)vs › | $2.34B | 42.26% | 35.06% | 13.24% | -28.82% |
| Recursion Pharmaceuticals, Inc. (RXRX)vs › | $2.51B | -867.87% | -840.98% | -774.76% | -1234.34% |
| Beam Therapeutics Inc. (BEAM)vs › | $2.64B | -274.57% | -464.41% | -382.79% | -92575.80% |
| Alamar Biosciences, Inc. (ALMR)vs › | $2.64B | -42.22% | -21.11% | -21.11% | -21.11% |
| Celldex Therapeutics, Inc. (CLDX)vs › | $2.17B | -19160.00% | -10969.44% | -7268.29% | -5243.17% |
| Acadia Healthcare Company, Inc. (ACHC)vs › | $2.69B | 10.06% | 14.13% | 15.87% | 13.57% |
| Aveanna Healthcare Holdings Inc. (AVAH)vs › | $2.69B | 11.12% | 10.91% | 6.08% | -3.97% |
| Addus HomeCare Corporation (ADUS)vs › | $2.11B | 10.04% | 9.32% | 8.61% | 7.98% |
| Alvotech (ALVO)vs › | $2.07B | 9.62% | 13.78% | -194.45% | -270.76% |
Gross Margin
18.6%
Operating Margin
-0.7%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 3.77% |
| 2026-03-31 | 3.65% |
| 2025-12-31 | -10.11% |
| 2025-09-30 | -4.91% |
| 2025-06-30 | -2.21% |
| 2025-03-31 | -0.28% |
| 2024-12-31 | -6.37% |
| 2024-09-30 | -2.65% |
| 2024-06-30 | 2.02% |
| 2024-03-31 | -6.54% |
| 2023-12-31 | -12.87% |
| 2023-09-30 | -10.98% |
| 2023-06-30 | -9.02% |
| 2023-03-31 | -24.75% |
| 2022-12-31 | -11.92% |
| 2022-09-30 | -8.65% |
| 2022-06-30 | -12.13% |
| 2022-03-31 | -10.00% |
| 2021-12-31 | -43.23% |
| 2021-09-30 | -34.94% |
| 2021-06-30 | -44.09% |
| 2021-03-31 | -59.45% |
| 2020-12-31 | -40.68% |
| 2020-09-30 | -12.79% |
| 2020-06-30 | 13.46% |
| 2020-03-31 | -16.09% |
| 2019-12-31 | 0.00% |
| 2019-09-30 | -26.06% |
| 2019-06-30 | -37.56% |
| 2019-03-31 | -37.56% |
